Average Co-Inventor Count = 8.72
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (18 from 2,943 patents)
2. Vertex Pharmaceuticals, Inc. (3 from 1,151 patents)
18 patents:
1. 12084438 - GCN2 inhibitors and uses thereof
2. 11696916 - Carboxamide-pyrimidine derivatives as SHP2 antagonists
3. 11033547 - Carboxamide-pyrimidine derivatives as SHP2 antagonists
4. 10988477 - GCN2 inhibitors and uses thereof
5. 10793563 - GCN2 inhibitors and uses thereof
6. 10413562 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
7. 10329270 - Heteroaryl compounds as BTK inhibitors and uses thereof
8. 10087166 - Cyclic amine azaheterocyclic carboxamides
9. 10080750 - Aminopyrimidine derivatives for use as modulators of kinase activity
10. 10016448 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
11. 10005784 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
12. 9738648 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
13. 9662330 - Aminopyrimidine derivatives for use as modulators of kinase activity
14. 9586938 - Cyclic amine azaheterocyclic carboxamides
15. 9580449 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity